Global Epigenetic Market Expected to Grow with a CAGR of 14%, 2019-2024 – ResearchAndMarkets.com – Business Wire

DUBLIN--(BUSINESS WIRE)--The "Epigenetic Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.

The future of the epigenetic market looks promising with opportunities in the pharmaceutical and biotechnology industries. The global epigenetic market is expected to grow with a CAGR of 14% from 2019 to 2024. The major growth drivers for this market are declining sequencing costs and time, increasing research activities and availability of government funding, and rising cancer prevalence.

A report of more than 150 pages is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the epigenetic market, then read this report.

Some of the features of Global Epigenetic Market 2019-2024: Trends, Forecast, and Opportunity Analysis include:

This report answers the following 11 key questions:

Q.1 What are some of the most promising potential, high-growth opportunities for the global epigenetic market by product, application, technology, and region?

Q.2 Which segments will grow at a faster pace and why?

Q.3 Which regions will grow at a faster pace and why?

Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the epigenetic market?

Q.5 What are the business risks and threats to the epigenetic market?

Q.6 What are emerging trends in this epigenetic market and the reasons behind them?

Q.7 What are some changing demands of customers in the epigenetic market?

Q.8 What are the new developments in the epigenetic market? Which companies are leading these developments?

Q.9 Who are the major players in this epigenetic market? What strategic initiatives are being implemented by key players for business growth?

Q.10 What are some of the competitive products and processes in this epigenetic area and how big of a threat do they pose for loss of market share via material or product substitution?

Q.11 What M & A activities have taken place in the last 5 years in epigenetic market?

Key Topics Covered:

1. Executive Summary

2. Market Background and Classifications

2.1: Introduction, Background, and Classifications

2.2: Supply Chain

2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2013 to 2024

3.1: Macroeconomic Trends and Forecast

3.2: Global Epigenetic Market: Trends and Forecast

3.3: Global Epigenetic Market by Product Type

3.3.1: Enzymes

3.3.2: Kits

3.3.3: Reagents

3.3.4: Bioinformatics Tools

3.4: Global Epigenetic Market by Application

3.4.1: Oncology

3.4.2: Non Oncology

3.5: Global Epigenetic Market by End Use Industry

3.5.1: Pharmaceutical

3.5.2: Biotechnology

3.5.3: Others

3.6: Global Epigenetic Market by Technology

3.6.1: DNA Methylation

3.6.2: Histone Methylation

3.6.3: Histone Acetylation

3.6.4: Large Noncoding RNA

3.6.5: MicroRNA Modification

3.6.6: Chromatin structures

3.6.7: Others

4. Market Trends and Forecast Analysis by Region

4.1: Global Epigenetic Market by Region

4.2: North American Epigenetic Market

4.2.1: Market by Product: Enzymes, Instruments and Consumables, Kits, Reagents, and Bioinformatics

Tools

4.2.2: Market by Application: Oncology and Non Oncology

4.2.3: Market by End Use Industry: Pharmaceutical, Biotechnology. And Others

4.2.4: Market by Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large

Noncoding RNA, MicroRNA Modification, Chromatin Structures, and Others

4.3: European Epigenetic Market

4.3.1: Market by Product: Enzymes, Instruments and Consumables, Kits, Reagents, and Bioinformatics

Tools

4.3.2: Market by Application: Oncology and Non Oncology

4.3.3: Market by End Use Industry: Pharmaceutical, Biotechnology. And Others

4.3.4: Market by Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large

Noncoding RNA, MicroRNA Modification, Chromatin Structures, and Others

4.4: APAC Epigenetic Market

4.4.1: Market by Product: Enzymes, Instruments and Consumables, Kits, Reagents, and Bioinformatics

Tools

4.4.2: Market by Application: Oncology and Non Oncology

4.4.3: Market by End Use Industry: Pharmaceutical, Biotechnology. And Others

4.4.4: Market by Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large

Noncoding RNA, MicroRNA Modification, Chromatin Structures, and Others

4.5: Row Epigenetic Market

4.5.1: Market by Product: Enzymes, Instruments and Consumables, Kits, Reagents, and Bioinformatics

Tools

4.5.2: Market by Application: Oncology and Non Oncology

4.5.3: Market by End Use Industry: Pharmaceutical, Biotechnology. And Others

4.5.4: Market by Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large

Noncoding RNA, MicroRNA Modification, Chromatin Structures, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis

5.2: Market Share Analysis

5.3: Operational Integration

5.4: Geographical Reach

5.5: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis

6.1.1: Growth Opportunities for Global Epigenetic Market by Product Type

6.1.2: Growth Opportunities for Global Epigenetic Market by Application

6.1.3: Growth Opportunities for Global Market by End Use Industry

6.1.4: Growth Opportunities for Global Market by Technology

6.1.5: Growth Opportunities for Global Epigenetic Market by Region

6.2: Emerging Trends in Global Epigenetic Market

6.3: Strategic Analysis

6.3.1: New Product Development

6.3.2: Capacity Expansion of Global Epigenetic Market

6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Market

7. Company Profiles of Leading Players

7.1: Illumina

7.2: Thermo Fisher Scientific

7.3: Merck Millipore

7.4: Abcam

7.5: Active Motif

7.6: Bio-Rad

Read more:
Global Epigenetic Market Expected to Grow with a CAGR of 14%, 2019-2024 - ResearchAndMarkets.com - Business Wire